These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31676867)

  • 21. Testing for rare conditions.
    Altman N; Krzywinski M
    Nat Methods; 2021 Mar; 18(3):224-225. PubMed ID: 33674793
    [No Abstract]   [Full Text] [Related]  

  • 22. Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing.
    Kingsmore SF; Dinwiddie DL; Miller NA; Soden SE; Saunders CJ
    Expert Rev Mol Diagn; 2011 Nov; 11(8):855-68. PubMed ID: 22022947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of Next-Generation Sequencing in Rare Renal Diseases].
    Cai ZY; Zhao JR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep Mutational Scanning: Calculating Enrichment Scores for Protein Variants from DNA Sequencing Output Files.
    Starita LM; Fields S
    Cold Spring Harb Protoc; 2015 Aug; 2015(8):781-3. PubMed ID: 26240406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical genomics and contextualizing genome variation in the diagnostic laboratory.
    Lupski JR; Liu P; Stankiewicz P; Carvalho CMB; Posey JE
    Expert Rev Mol Diagn; 2020 Oct; 20(10):995-1002. PubMed ID: 32954863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostics in human genetics : Integration of phenotypic and genomic data].
    Köhler S; Robinson PN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):542-549. PubMed ID: 28293716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].
    Sun J; Huang Y; Wang X; Li W; An D; Gao Y; Xiong H; Zhou Z; Xu X; Deng X; Wang X; Huang H; Peng Z; Zhang W; Yu S; Wang L; Gu W; Huang S; Shen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):345-351. PubMed ID: 32128756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rare diseases are common].
    Has C; Giehl K
    Hautarzt; 2014 Jun; 65(6):488-9. PubMed ID: 24898502
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel phenotype-disease matching tool for rare genetic diseases.
    Chen J; Xu H; Jegga A; Zhang K; White PS; Zhang G
    Genet Med; 2019 Feb; 21(2):339-346. PubMed ID: 29895857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenopolis: an open platform for harmonization and analysis of genetic and phenotypic data.
    Pontikos N; Yu J; Moghul I; Withington L; Blanco-Kelly F; Vulliamy T; Wong TLE; Murphy C; Cipriani V; Fiorentino A; Arno G; Greene D; Jacobsen JOB; Clark T; Gregory DS; Nemeth AM; Halford S; Inglehearn CF; Downes S; Black GC; Webster AR; Hardcastle AJ; ; Plagnol V
    Bioinformatics; 2017 Aug; 33(15):2421-2423. PubMed ID: 28334266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():14-8. PubMed ID: 27137856
    [No Abstract]   [Full Text] [Related]  

  • 32. Next Generation Diagnostics for Rare Neurological Diseases: The Future is Here.
    Innes AM; Boycott KM
    Can J Neurol Sci; 2014 May; 41(3):299-300. PubMed ID: 24718813
    [No Abstract]   [Full Text] [Related]  

  • 33. Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions.
    Fricke WF; Rasko DA
    Nat Rev Genet; 2014 Jan; 15(1):49-55. PubMed ID: 24281148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next generation sequencing technologies for rare Mendelian disorders: striking potential and ongoing challenges.
    Hoffjan S
    Mol Cell Probes; 2015 Oct; 29(5):259. PubMed ID: 26257290
    [No Abstract]   [Full Text] [Related]  

  • 36. Which genes to assess in the NGS diagnostics of intellectual disability? The case for a consensus database-driven and expert-curated approach.
    Erger F; Schaaf CP; Netzer C
    Mol Cell Probes; 2019 Jun; 45():84-88. PubMed ID: 30914295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genodermatoses with malignant skin tumors].
    Hübinger L; Frank J
    Hautarzt; 2014 Jun; 65(6):527-35. PubMed ID: 24898507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CrowdVariant: a crowdsourcing approach to classify copy number variants.
    Greenside P; Zook J; Salit M; Cule M; Poplin R; DePristo M
    Pac Symp Biocomput; 2019; 24():224-235. PubMed ID: 30864325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical standards and guidelines: molecular genetic testing for ultra-rare disorders.
    Maddalena A; Bale S; Das S; Grody W; Richards S;
    Genet Med; 2005 Oct; 7(8):571-83. PubMed ID: 16247296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic guidelines for newborns who screen positive in newborn screening.
    Kronn D; Mofidi S; Braverman N; Harris K;
    Genet Med; 2010 Dec; 12(12 Suppl):S251-5. PubMed ID: 21150371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.